QuickVue SARS Antigen test by Quidel Corporation. C redit: AptarGroup, Inc.

Consumer packaging solution provider Aptar has partnered with Quidel Corporation to provide its Activ-Film technology for the latter’s diagnostic tool.

The technology will be used to safeguard Quidel’s QuickVue SARS Antigen test for Covid-19.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Activ-Film leverages Aptar’s proprietary 3-Phase Activ-Polymer technology, which is currently used to safeguard a range of electrochemical, lateral flow and molecular diagnostic test kits.

Aptar president and CEO Stephan Tanda said: “We are pleased to partner with Quidel Corporation on this critical diagnostic tool and help bring the QuickVue SARS Antigen test to the market.

“Our material science Activ-Film technology protects the test strips, helping to provide quick, reliable results. We will continue to live up to our purpose and responsibility to society by providing solutions that protect critical Covid-19 diagnostic kits, along with dispensing solutions for medicines and consumer products needed by millions of people each day.”

Diagnostic healthcare solutions manufacturer Quidel developed the QuickVue SARS Antigen test as a visually read point-of-care rapid antigen test.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Recently, the test received Emergency Use Authorisation (EUA) from the US Food and Drug Administration (FDA). It delivers test results in ten minutes and requires no supplemental instrumentation.

According to Quidel, the tool provides “expanded access to affordable and accurate Covid-19 testing”.

Headquartered in Crystal Lake, Illinois, Aptar designs and manufactures a wide range of drug delivery, consumer product dispensing and active material solutions.